Steve is a Principal Scientist in the Molecular Assays Group at CST, where he develops antibody-based tools such as ELISA and identifies antibody pairs for use in other ELISA-like pair-based assays. Steve received his PhD in Cell and Molecular Biology from Boston University investigating transcriptional programs downstream of growth factor-induced signaling pathways and later worked on identifying critical pathways involved in fibrotic disease.
